Cargando…

Loss of androgen receptor signaling in prostate cancer‐associated fibroblasts (CAFs) promotes CCL2‐ and CXCL8‐mediated cancer cell migration

Fibroblasts are abundantly present in the prostate tumor microenvironment (TME), including cancer‐associated fibroblasts (CAFs) which play a key role in cancer development. Androgen receptor (AR) signaling is the main driver of prostate cancer (PCa) progression, and stromal cells in the TME also exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cioni, Bianca, Nevedomskaya, Ekaterina, Melis, Monique H. M., van Burgsteden, Johan, Stelloo, Suzan, Hodel, Emma, Spinozzi, Daniele, de Jong, Jeroen, van der Poel, Henk, de Boer, Jan Paul, Wessels, Lodewyk F. A., Zwart, Wilbert, Bergman, Andries M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068356/ https://www.ncbi.nlm.nih.gov/pubmed/29808619 http://dx.doi.org/10.1002/1878-0261.12327

Ejemplares similares

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015)

Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015)

Optimized ChIP-seq method facilitates transcription factor profiling in human tumors
por: Singh, Abhishek A, et al.
Publicado: (2018)

Genome-wide epigenetic profiling of breast cancer tumors treated with aromatase inhibitors
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2014)

mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma
por: Stelloo, Suzan, et al.
Publicado: (2016)

Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion
por: Cioni, Bianca, et al.
Publicado: (2020)

Integrative epigenetic taxonomy of primary prostate cancer
por: Stelloo, Suzan, et al.
Publicado: (2018)

The Prognostic Potential of Human Prostate Cancer-Associated Macrophage Subtypes as Revealed by Single-Cell Transcriptomics
por: Siefert, Joseph C., et al.
Publicado: (2021)

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018)

The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model
por: Melis, Monique H.M., et al.
Publicado: (2017)

TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
por: Palit, Sander AL, et al.
Publicado: (2019)

Functional mapping of androgen receptor enhancer activity
por: Huang, Chia-Chi Flora, et al.
Publicado: (2021)

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
por: Severson, Tesa, et al.
Publicado: (2022)

Radium-223 Treatment of Patients with Metastatic Castration Resistant Prostate Cancer: Biomarkers for Stratification and Response Evaluation
por: van der Zande, Kim, et al.
Publicado: (2021)

Genomic data integration by WON-PARAFAC identifies interpretable factors for predicting drug-sensitivity in vivo
por: Kim, Yongsoo, et al.
Publicado: (2019)

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential
por: Kneppers, Jeroen, et al.
Publicado: (2022)

Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases
por: Severson, Tesa M., et al.
Publicado: (2021)

Gene expression pattern of CCL2, CCL3, and CXCL8 in patients with bipolar disorder
por: Ghoryani, Mohsen, et al.
Publicado: (2019)

Rapid Internalization and Nuclear Translocation of CCL5 and CXCL4 in Endothelial Cells
por: Dickhout, Annemiek, et al.
Publicado: (2021)

Higher Expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 Chemokines in the Skin Associated with Parasite Density in Canine Visceral Leishmaniasis
por: Menezes-Souza, Daniel, et al.
Publicado: (2012)

Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)
por: van Rossum, Huub H., et al.
Publicado: (2023)

Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation
por: Severson, Tesa M., et al.
Publicado: (2016)

Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains
por: van Gemst, J. J., et al.
Publicado: (2018)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
por: Hickey, Theresa E, et al.
Publicado: (2020)

Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer
por: Long, Mark D., et al.
Publicado: (2021)

The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer
por: Van der Roest, Rosanne CV., et al.
Publicado: (2016)

Integrin Regulation of CAF Differentiation and Function
por: DiPersio, C. Michael, et al.
Publicado: (2019)

CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage
por: Landreneau, Margaret J., et al.
Publicado: (2018)

Increased CCL24 and CXCL7 levels in the cerebrospinal fluid of patients with neurosyphilis
por: Li, Xin‐Xin, et al.
Publicado: (2020)

CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion
por: Fan, Long, et al.
Publicado: (2017)

A Study of IFN-α-Induced Chemokines CCL2, CXCL10 and CCL19 in Patients with Systemic Lupus Erythematosu
por: Geneva-Popova, Mariela Gencheva, et al.
Publicado: (2022)

Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model
por: Passier, Margot, et al.
Publicado: (2023)

Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells
por: Pharoah, Daniel S, et al.
Publicado: (2006)

Murine Placental Erythroid Cells Are Mainly Represented by CD45(+) Immunosuppressive Erythroid Cells and Secrete CXCL1, CCL2, CCL3 and CCL4 Chemokines
por: Nazarov, Kirill, et al.
Publicado: (2023)

Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients
por: Carvalheiro, Tiago, et al.
Publicado: (2017)

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
por: Geng, Xinglong, et al.
Publicado: (2021)

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
por: Sharma, Sherven, et al.
Publicado: (2003)

A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer
por: Palit, Sander A. L., et al.
Publicado: (2021)

Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation
por: Baumgart, Simon J., et al.
Publicado: (2020)

CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma
por: Zhang, Hongfang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9kmqsr1k782nuacvlq0updhr0n